JPRN-UMIN000001719未知未知
Tokushima Anti-Oxidation Clinical Trial In hypertensives, Cilnidipine versus Amlodipine - TACTICA
Cardiovascular Medicine, The University of Tokushima Institute of Health Biosciences, Graduate School0 个研究点目标入组 50 人开始时间: 2009年2月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Malignant hypertension 2.Pregnant women,or Women suspected of being pregnant. 3.Severe liver disorder. 4.Patients who are inadequate to enter this study due to the other reasons by physician's judgments.
研究者
相似试验
已完成
不适用
Tokushima Anti-Oxidation and RAS inhibition Clinical Trial In hypertensives, Cilnidipine versus AmlodipinehypertensionJPRN-UMIN000006544Cardiovascular Medicine. The University of Tokushima Institute of Health Biosciences, Graduate School.25
已完成
1 期
Control Body Tumor Microenvironment by Amelioration of Chronic Stress with Chinese Medicine of of Sanhuang Decoction (SHD) During Endocrine Treatment in Breast Cancer PatientsBreast cancerITMCTR2000004194Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
进行中（未招募）
1 期
The pAToMiUM Trial: testing a dietary supplement for men aimed at reducing unexplained miscarriageEUCTR2019-000315-91-GBniversity of Birmingham30
进行中（未招募）
3 期
Pilot antioxidant therapy of men in unexplained miscarriage: the pAToMiUM trialMiscarriage, elevated sperm DNA fragmentationPregnancy and ChildbirthISRCTN91556363niversity of Birmingham15
进行中（未招募）
1 期
High Dose Antioxidant Treatment for Patients with Cystic FibrosisCystic FibrosisEUCTR2013-005481-19-DKAarhus University Hospital